rsv merck - Search News

News

Merck's RSV shot for infants gets key approval

Merck’s RSV shot for infants gets key approval despite RFK Jr.’s panel shakeup

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who has previously made statements skeptical of vaccines,

UPI on MSN · 2d

New CDC vaccine committee OKs Merck RSV shot for infants

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

Reuters on MSN · 2d

Kennedy's new US vaccine panel backs Merck's RSV drug for infants

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend use of Merck's recently approved RSV antibody drug for infants 8 months or younger whose mothers did not receive a preventive shot during pregnancy.

STAT2d

Pharmalittle: We’re reading about the gray market for obesity meds, an RSV drug recommendation, and more

Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...

RSV endangers thousands of Arizona babies a year. Will this shot help?

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

Medical Dialogues7h

Merck Enflonsia wins ACIP backing for RSV protection in infants under 8 months

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results